Dr. Myron H. Brand, MD

Dr. Brand practices at Yale Medicine in New Haven, Connecticut.

Dr. Brand's NPI, 1336280080, was assigned on February 8, 2007. Dr. Brand graduated from University of North Carolina School of Medicine in 1972. Dr. Brand holds Connecticut license 016172.

Dr. Brand's primary practice is Yale Medicine, at 50 Division St, New Haven, CT 06511 in South Central Ct County. The practice phone is (203) 785-2140.

Dr. Brand's primary practice is Yale Medicine in New Haven, Connecticut. Dr. Brand is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Brand to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brand practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Brand's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Brand is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Brand is licensed in Connecticut.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroduodenitis, gastroenteritis and gastrointestinal bleeding among the conditions Dr. Brand treats.

CMS data shows 9,586 Medicare services from Dr. Brand across 13 procedure codes in 2024, for 330 Medicare patients. Medicare paid $242,960 for them.

CMS counts 330 Medicare patients who saw Dr. Brand in 2024. The largest group is 65 to 74, with 145 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brand's median patient age at 69, with 50% women.

In 2024, Dr. Brand wrote 1,870 Medicare Part D claims for 481 patients. 80% of them were for generic drugs. CMS names the drug for 1,606 of them, across 36 drugs with 11 or more claims each, at $3,134,205 in total drug cost. In 2023, CMS named 1,481 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Brand for performance year 2024, reported as part of a group. Dr. Brand accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Brand as offering telehealth. CMS counts 84 procedures of colonoscopy by Dr. Brand, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 20 papers to Dr. Brand, published from 2014 to 2024. The most frequent topics are Gastrointestinal Hemorrhage, Crohn Disease and Adalimumab. Dr. Brand has published most often in Inflamm Bowel Dis. Dr. Brand's most frequent co-authors are David G. Binion, MD, Raymond Keith Cross, MD and David John Keljo, MD, PhD.

CMS Open Payments shows 1,102 general payments to Dr. Brand from 33 drug and device companies from 2016 to 2023. Speaker and faculty fees make up the largest share, 72% of the total. Abbvie Inc. paid the most, $82,768.

Dmand AI lists 3 awards for Dr. Brand, most recently ACG Fellow in 2013.

Dr. Brand graduated from University of North Carolina School of Medicine in 1972. Dr. Brand is a member of ACG.

Dr. Brand is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.